Neuralink Gets FDA Approval for Human Trials of Brain Implant Device to Help Paralyzed Patients
-
Elon Musk's brain-implant startup Neuralink got approval to recruit paralyzed patients for first human trial of its experimental brain-computer interface device.
-
The 6-year study aims to enable paralyzed people to control a computer cursor or keyboard using just their thoughts.
-
Neuralink seeks to develop an all-encompassing brain implant to help humans keep up with AI, but experts have concerns about ethics and animal testing.
-
FDA initially denied fast-track request but approved investigational device exemption for clinical studies in May.
-
If proven safe, it could still take decades before Neuralink's device is cleared for use outside the trial.